The Clinical Takeaway: Shingles – Why it is a serious problem and why the new vaccine is a good development
The Clinical Takeaway: Shingles – Why it is a serious problem and why the new vaccine is a good development
In this episode:
– Post shingles, QOL is significantly and permanently reduced
– Biological agents, CMV and an ageing population all contribute to increased shingles risk
– There is a new herpes zoster vaccine available in Australia
Host: Dr David Lim, GP
Guest: Prof Paul Van Buynder, Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland
Total time: 37 mins
Log your own CPD by following these easy steps: |
| This educational activity was developed by Healthed at the request of and with funding from GSK. |
